{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:10:31Z","timestamp":1761898231000,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.clinre.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T17:01:44Z","timestamp":1363885304000},"page":"216-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoantibodies in autoimmune hepatitis: Anti-liver kidney microsome type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) antibodies"],"prefix":"10.1016","volume":"37","author":[{"given":"Catherine","family":"Johanet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Ballot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2013.02.004_bib0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0050","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0005","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bmj.2.5910.80","article-title":"Hepatic disorders associated with liver-kidney microsomal antibodies","volume":"2","author":"Smith","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.clinre.2013.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.168.2.801","article-title":"Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily","volume":"168","author":"Gueguen","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2013.02.004_bib0025","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2013.02.004_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.clinre.2013.02.004_bib0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.1840160304","article-title":"Liver\/kidney microsome antibody type 1 and hepatitis C virus infection","volume":"16","author":"Lunel","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.1994.tb06585.x","article-title":"Differences in immune recognition of cytochrome P450 2D6 by liver kidney microsome (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection","volume":"97","author":"Ma","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2133\/dmpk.25.84","article-title":"LKM-1 sera from autoimmune hepatitis patients that recognize Erp57, carboxylesterase 1 and CYP2D6","volume":"1","author":"Komurasaki","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinre.2013.02.004_bib0055","first-page":"58","article-title":"Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease","volume":"21","author":"Han","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.02.004_bib0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.yexcr.2003.09.009","article-title":"Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis","volume":"292","author":"Renous","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.clinre.2013.02.004_bib0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2249.1998.00754.x","article-title":"Arginosuccinate lyase: a new autoantigen in liver disease","volume":"114","author":"Pelli","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0085","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2334-4-4","article-title":"The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C","volume":"4","author":"Wasmuth","year":"2004","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clinre.2013.02.004_bib0095","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1086\/379018","article-title":"Non-organ-specific autoantibodies in children with chronic hepatits C: clinical significance and impact on interferon treatment","volume":"37","author":"Muratori","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinre.2013.02.004_bib0100","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2013.02.004_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-1759(02)00016-9","article-title":"Autoantibodies detection in type 2 autoimmune hepatitis using a chimera recombinant protein","volume":"262","author":"Vitozzi","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.clinre.2013.02.004_bib0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","article-title":"Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody","volume":"2","author":"Brinoux-Henno","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2249.2001.01645.x","article-title":"Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda","volume":"126","author":"Ma","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2013.02.004_bib0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clinre.2013.02.004_bib0130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10620-011-2017-z","article-title":"Autoantibody-negative autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2013.02.004_bib0135","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3748\/wjg.15.1025","article-title":"Influence of genes, age, and environment on the onset of autoimmune hepatitis","volume":"15","author":"Beland","year":"2009","journal-title":"World J Gastroenterol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:16:36Z","timestamp":1761894996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740113000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S2210740113000405"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2013.02.004","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in autoimmune hepatitis: Anti-liver kidney microsome type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) antibodies","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2013.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}